Zynex Inc (ZYXI) - Total Assets
Based on the latest financial reports, Zynex Inc (ZYXI) holds total assets worth $45.32 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Zynex Inc (ZYXI) net assets for net asset value and shareholders' equity analysis.
Zynex Inc - Total Assets Trend (1998–2024)
This chart illustrates how Zynex Inc's total assets have evolved over time, based on quarterly financial data.
Zynex Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Zynex Inc's total assets of $45.32 Million consist of 61.6% current assets and 38.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 32.5% |
| Accounts Receivable | $18.02 Million | 14.8% |
| Inventory | $13.92 Million | 11.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.25 Million | 5.9% |
| Goodwill | $20.40 Million | 16.7% |
Asset Composition Trend (1998–2024)
This chart illustrates how Zynex Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ZYXI market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zynex Inc's current assets represent 61.6% of total assets in 2024, a decrease from 100.0% in 1998.
- Cash Position: Cash and equivalents constituted 32.5% of total assets in 2024, up from 0.0% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 1998.
- Asset Diversification: The largest asset category is goodwill at 16.7% of total assets.
Zynex Inc Competitors by Total Assets
Key competitors of Zynex Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
Zynex Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.47 | 3.94 | 6.23 |
| Quick Ratio | 0.32 | 3.15 | 5.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-41.83 Million | $58.48 Million | $52.91 Million |
Zynex Inc - Advanced Valuation Insights
This section examines the relationship between Zynex Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 34.84 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -10.8% |
| Total Assets | $122.08 Million |
| Market Capitalization | $2.61 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zynex Inc's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Zynex Inc's assets decreased by 10.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Zynex Inc (1998–2024)
The table below shows the annual total assets of Zynex Inc from 1998 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $122.08 Million | -10.83% |
| 2023-12-31 | $136.90 Million | +13.75% |
| 2022-12-31 | $120.35 Million | -9.70% |
| 2021-12-31 | $133.27 Million | +79.56% |
| 2020-12-31 | $74.22 Million | +162.49% |
| 2019-12-31 | $28.28 Million | +74.72% |
| 2018-12-31 | $16.18 Million | +81.25% |
| 2017-12-31 | $8.93 Million | +118.26% |
| 2016-12-31 | $4.09 Million | +10.69% |
| 2015-12-31 | $3.70 Million | -48.05% |
| 2014-12-31 | $7.11 Million | -58.69% |
| 2013-12-31 | $17.22 Million | -33.53% |
| 2012-12-31 | $25.91 Million | +18.93% |
| 2011-12-31 | $21.79 Million | +38.75% |
| 2010-12-31 | $15.70 Million | +31.61% |
| 2009-12-31 | $11.93 Million | +10.63% |
| 2008-12-31 | $10.78 Million | +50.30% |
| 2007-12-31 | $7.18 Million | +159.19% |
| 2006-12-31 | $2.77 Million | +105.84% |
| 2005-12-31 | $1.34 Million | +70.33% |
| 2004-12-31 | $789.60K | +83.63% |
| 2003-12-31 | $430.00K | +193.99% |
| 2000-12-31 | $146.26K | +119788.52% |
| 1999-12-31 | $122.00 | 0.00% |
| 1998-12-31 | $122.00 | -- |
About Zynex Inc
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more